Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Shareholders' Equity

v3.21.2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Shares
Additional  Paid-In Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Mar. 31, 2020     280,853,000        
Beginning balance at Mar. 31, 2020 $ 965,704 $ 306 $ 281 $ 1,573,347 $ (589,819) $ 306 $ (18,105)
Increase (Decrease) in Partners' Capital [Roll Forward]              
Foreign currency translation (2,342)           (2,342)
Restricted stock units vested (in shares)     132,000        
Restricted stock awards forfeited (in shares)     (88,000)        
Issuance of common stock related to employee stock purchase plan (in shares)     159,000        
Issuance of common stock related to employee stock purchase plan 3,592     3,592      
Share-based compensation 12,672     12,672      
Equity repurchases (13)     (13)      
Net income 12,865       12,865    
Ending balance (in shares) at Jun. 30, 2020     281,056,000        
Ending balance at Jun. 30, 2020 $ 992,784   $ 281 1,589,598 (576,648)   (20,447)
Beginning balance (in shares) at Mar. 31, 2021 283,130,238   283,130,000        
Beginning balance at Mar. 31, 2021 $ 1,113,601   $ 283 1,653,328 (513,799)   (26,211)
Increase (Decrease) in Partners' Capital [Roll Forward]              
Foreign currency translation (1,658)           (1,658)
Restricted stock units vested (in shares)     496,000        
Restricted stock units vested 0   $ 1 (1)      
Issuance of common stock related to employee stock purchase plan (in shares)     204,000        
Issuance of common stock related to employee stock purchase plan $ 6,593     6,593      
Exercise of stock options (in shares) 388,000   388,000        
Exercise of stock options $ 7,886     7,886      
Share-based compensation 19,252     19,252      
Equity repurchases (14)     (14)      
Net income $ 13,294       13,294    
Ending balance (in shares) at Jun. 30, 2021 284,217,750   284,218,000        
Ending balance at Jun. 30, 2021 $ 1,158,954   $ 284 $ 1,687,044 $ (500,505)   $ (27,869)